文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

梅毒快速诊断检测算法的性能与成本比较:孕妇与MSM人群的建模研究

Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study.
PubMed 文献 · Lancet Infect Dis · 2025-11-21

该建模研究比较三种基于快速诊断检测(RDT)的梅毒检测算法在孕妇和男男性行为者(MSM)中的性能与成本。在孕妇中,改良双重RDT漏诊活动性病例比仅密螺旋体RDT少至少80%,但过度治疗更多;标准双重RDT在MSM中过度治疗最少但漏诊最多。结论是尚无单一算法适用于所有场景。

要点

  • 孕妇筛查中仅密螺旋体RDT成本低但漏诊多,改良双重RDT漏诊少但过度治疗多。
  • MSM人群中标准双重RDT过度治疗最少,但漏诊病例多于其他两种算法。
  • 序贯算法(先仅密螺旋体RDT后改良双重RDT)可减少漏诊并大幅降低过度治疗。

核心结论

  • 没有单一RDT算法在所有场景下最优。
  • 仅密螺旋体RDT仍适合产前筛查,而标准或改良双重RDT可能更适合梅毒高危人群如MSM。

研究设计与样本

  • 开放源代码决策分析模型,比较三种RDT算法,评估队列为100 000人,时间范围为单次检测 episode。

主要发现

  • 孕妇中,改良双重RDT漏诊活动性病例比仅密螺旋体RDT少至少80%,但过度治疗更多。
  • MSM中,标准双重RDT每10万人漏诊125例、过度治疗999例(同场景),漏诊多于其他两种算法但过度治疗最少。
  • RDT成本是所有三种算法的主要成本驱动因素;敏感性分析中序贯算法减少漏诊并大幅降低过度治疗。

关键数值与推荐

  • 孕妇比较仅密螺旋体RDT与改良双重RDT;MSM评估全部三种算法。
  • 改良双重RDT定义为任一成分阳性即治疗;标准双重RDT定义为两个成分均阳性才治疗。

临床怎么用

  • 产前筛查可考虑仅密螺旋体RDT以降低成本,但需权衡漏诊风险。
  • MSM等高危人群可优先选择标准或改良双重RDT以减少漏诊,但需关注过度治疗。
  • 序贯算法(先仅密螺旋体RDT后改良双重RDT)可能平衡漏诊与过度治疗。

局限性

  • 成本输入基于中低收入国家典型场景,可能不适用于其他地区。
  • 模型未考虑治疗依从性、后续随访等现实因素。
  • 敏感性分析仅探索了检测性能、成本和替代算法选项的不确定性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Syphilis remains a global public health concern, particularly among pregnant individuals and men who have sex with men (MSM). Rapid diagnostic tests (RDTs) enable same-day diagnosis and treatment, but the optimal testing algorithm depends on local epidemiology. We aim to evaluate the performance and cost-effectiveness of three RDT-based algorithms across varying syphilis prevalence in antenatal and MSM populations. METHODS: We developed an open-source decision-analytic model to compare: (1) a treponemal-only RDT (T-RDT); (2) a standard dual treponemal and non-treponemal RDT (T/NT-RDT; for which treatment is recommended if both components are positive); and (3) a modified T/NT-RDT, for which anyone positive on either component receives treatment, reflecting real-world practice when a person's syphilis history is unclear. The primary outcomes were missed and overtreated cases, evaluated in cohorts of 100 000 individuals. We also assessed cost per person tested (in 2025 US dollars). Cost inputs reflected settings typical of low-income and middle-income countries. Analyses were stratified by population: among pregnant individuals, we compared the T-RDT and modified T/NT-RDT, and for MSM, all three algorithms were evaluated. The time horizon was a single testing episode with syphilis prevalence ranging from 0·5% to 20%. Sensitivity analyses explored uncertainty in test performance, costs, and alternative algorithm options. FINDINGS: Among pregnant individuals, the modified T/NT-RDT missed at least 80% fewer active cases than the T-RDT but had more overtreated cases. For example, at a syphilis prevalence of 0·5%, with a RDT sensitivity of 85% and specificity of 90%, the modified T/NT-RDT missed 10 active cases and overtreated 18 948 cases per 100 000 individuals, compared with 68 missed cases and 9993 overtreated cases with the T-RDT. The T-RDT ($1·09-$1·51 per person tested) cost less than the modified T/NT-RDT ($3·59-$4·12). Among MSM, the modified T/NT-RDT missed the fewest cases but increased overtreatment. The standard T/NT-RDT (costing $3·59-$3·87 per person tested) had the lowest rates of overtreatment but missed more cases than either alternative (ie, in the same scenario with a syphilis prevalence of 0·5%, RDT sensitivity of 85%, and specificity of 90%, the standard T/NT-RDT missed 125 active cases and overtreated 999 cases per 100 000 individuals). RDT costs were the main cost driver in all three algorithms. In sensitivity analyses, a sequential algorithm consisting of T-RDT followed by the modified T/NT-RDT reduced missed cases compared with the standard T/NT-RDT, and substantially reduced overtreatment relative to the T-RDT and modified T/NT-RDT. INTERPRETATION: No single algorithm was optimal across all settings. T-RDTs remain suitable for antenatal screening, but the standard or modified T/NT-RDT might be preferable for populations at high risk for syphilis, such as MSM. FUNDING: Australian National Health and Medical Research Council Emerging Leadership Investigator Grants and an Australian Government Research Training Program scholarship.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Chow EPF, Zhang L, et al. Comparison of the performance and costs of testing algorithms using rapid diagnostic tests for detection and treatment of syphilis among pregnant individuals and men who have sex with men: a modelling study. Lancet Infect Dis. 2025. PMID: 41285141. doi:10.1016/S1473-3099(25)00588-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。